Device Trial Radar · NCT04929470
Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss
Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Jul 6, 2021
Primary completion
Feb 5, 2026
Study completion Feb 5, 2026
Sponsor
- Lead sponsor
- Advanced Bionics AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
This is a prospective study designed to evaluate the safety and performance of the HiResTM Ultra Cl HiFocusTM SlimJ Electrode and HiResTM Ultra 3D Cl HiFocusTM SlimJ Electrode (Ultra X) under normal conditions of use as it is approved for this device. Participants receive interventions as part of routine medical care.
Conditions
- Cochlear Hearing Loss
Interventions
cochlear implantationDevice
patients receive a cochlear implantation within clinical routine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freiburger Monosyllables Score in QuietTime frame: 6 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Westfälische Wilhelms-Universität Münster
Münster, Germany
HNO-Klinik Düsseldorf
Düsseldorf, Düsseldorf, Germany
Unfallkrankenhaus Berlin (UKB)
Berlin, State of Berlin, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.